BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10508511)

  • 1. Fv2 encodes a truncated form of the Stk receptor tyrosine kinase.
    Persons DA; Paulson RF; Loyd MR; Herley MT; Bodner SM; Bernstein A; Correll PH; Ney PA
    Nat Genet; 1999 Oct; 23(2):159-65. PubMed ID: 10508511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sf-Stk kinase activity and the Grb2 binding site are required for Epo-independent growth of primary erythroblasts infected with Friend virus.
    Finkelstein LD; Ney PA; Liu QP; Paulson RF; Correll PH
    Oncogene; 2002 May; 21(22):3562-70. PubMed ID: 12032858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo and in vivo biological effects of a truncated form of the receptor tyrosine kinase stk when activated by interaction with the friend spleen focus-forming virus envelope glycoprotein or by point mutation.
    Rulli K; Yugawa T; Hanson C; Thompson D; Ruscetti S; Nishigaki K
    J Virol; 2004 May; 78(9):4573-81. PubMed ID: 15078939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel Stat3 binding motif in Gab2 mediates transformation of primary hematopoietic cells by the Stk/Ron receptor tyrosine kinase in response to Friend virus infection.
    Ni S; Zhao C; Feng GS; Paulson RF; Correll PH
    Mol Cell Biol; 2007 May; 27(10):3708-15. PubMed ID: 17353274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to friend virus-induced erythroleukemia in W/W(v) mice is caused by a spleen-specific defect which results in a severe reduction in target cells and a lack of Sf-Stk expression.
    Subramanian A; Teal HE; Correll PH; Paulson RF
    J Virol; 2005 Dec; 79(23):14586-94. PubMed ID: 16282458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation of the Lyn tyrosine kinase delays the progression of Friend virus induced erythroleukemia without affecting susceptibility.
    Subramanian A; Hegde S; Correll PH; Paulson RF
    Leuk Res; 2006 Sep; 30(9):1141-9. PubMed ID: 16527351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A naturally occurring point substitution in Cdc25A, and not Fv2/Stk, is associated with altered cell-cycle status of early erythroid progenitor cells.
    Melkun E; Pilione M; Paulson RF
    Blood; 2002 Nov; 100(10):3804-11. PubMed ID: 12411323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The envelope glycoprotein of friend spleen focus-forming virus covalently interacts with and constitutively activates a truncated form of the receptor tyrosine kinase Stk.
    Nishigaki K; Thompson D; Hanson C; Yugawa T; Ruscetti S
    J Virol; 2001 Sep; 75(17):7893-903. PubMed ID: 11483734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GRB2-mediated recruitment of GAB2, but not GAB1, to SF-STK supports the expansion of Friend virus-infected erythroid progenitor cells.
    Teal HE; Ni S; Xu J; Finkelstein LD; Cheng AM; Paulson RF; Feng GS; Correll PH
    Oncogene; 2006 Apr; 25(17):2433-43. PubMed ID: 16314834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the N-terminally truncated form of the Stk receptor tyrosine kinase Sf-Stk by Friend virus-encoded gp55 is mediated by cysteine residues in the ecotropic domain of gp55 and the extracellular domain of Sf-Stk.
    He S; Ni S; Hegde S; Wang X; Sharda DR; August A; Paulson RF; Hankey PA
    J Virol; 2010 Mar; 84(5):2223-35. PubMed ID: 20016000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of N-terminal sequences of the tyrosine kinase sf-Stk in transformation of rodent fibroblasts by variants of Friend spleen focus-forming virus.
    Umehara D; Kawamura M; Odahara Y; Watanabe S; Hanson C; Ruscetti S; Nishigaki K
    Int J Cancer; 2012 Sep; 131(5):1083-94. PubMed ID: 22034044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STK/RON receptor tyrosine kinase mediates both apoptotic and growth signals via the multifunctional docking site conserved among the HGF receptor family.
    Iwama A; Yamaguchi N; Suda T
    EMBO J; 1996 Nov; 15(21):5866-75. PubMed ID: 8918464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage-stimulating protein cooperates with erythropoietin to induce colony formation and MAP kinase activation in primary erythroid progenitor cells.
    Teal HE; Craici A; Paulson RF; Correll PH
    J Hematother Stem Cell Res; 2003 Apr; 12(2):165-77. PubMed ID: 12804176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility and resistance to Moloney murine leukemia virus-induced promonocytic leukemia.
    Nazarov V; Hilbert D; Wolff L
    Virology; 1994 Dec; 205(2):479-85. PubMed ID: 7975249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of phosphatidylinositol 3-kinase in friend spleen focus-forming virus-induced erythroid disease.
    Umehara D; Watanabe S; Ochi H; Anai Y; Ahmed N; Kannagi M; Hanson C; Ruscetti S; Nishigaki K
    J Virol; 2010 Aug; 84(15):7675-82. PubMed ID: 20504929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular regulation of receptor tyrosine kinases in hematopoietic malignancies.
    Correll PH; Paulson RF; Wei X
    Gene; 2006 Jun; 374():26-38. PubMed ID: 16524673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of Friend leukemia virus.
    Ikawa Y
    Leukemia; 1997 Apr; 11 Suppl 3():152-4. PubMed ID: 9209327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of p53 in F-MuLV induced-erythroleukemias accelerates the acquisition of mutational events that confers immortality and growth factor independence.
    Wong KS; Li YJ; Howard J; Ben-David Y
    Oncogene; 1999 Sep; 18(40):5525-34. PubMed ID: 10523829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow transplantation from Fv-4-resistant donors rescues Friend leukemia virus-infected mice from leukemia: a model of bone marrow transplantation therapy against retroviral infection.
    Kitagawa M; Kamisaku H; Aizawa S; Sado T
    Leukemia; 1994 Dec; 8(12):2200-6. PubMed ID: 7808008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of Fv-4 resistant gene product in Friend leukemia virus-resistant Fv-4r mouse strain.
    Kitagawa M; Aizawa S; Kamisaku H; Sado T; Ikeda H; Hirokawa K
    Exp Hematol; 1996 Oct; 24(12):1423-31. PubMed ID: 8913289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.